ClinicalTrials.gg
Sign In

Drug

DA-302168S clinical trials

Also written DA-302168S.

studies test it
6
open now
3
in phase 3
1
first study started
2024

Keep track of what changes. Save the DA-302168S studies recruiting or about to start, and get an email each week — studies that open, close, add sites or post results.

Watch these studies

How studies write it

Studies that test it under each name

Development codes

DA-302168S
6

Studies by the year they started

6 studies that test it; most in 2026 (3)

Studies that test DA-302168S, by start year
YearStudies
20242
20251
20263

By phase

A phase 1/2 study counts in both.

Phase 1
3
Phase 2
2
Phase 3
1

What it is tested for

Each study’s main condition, where its own words name it.

Obesity
3
Overweight
2
Diabetes Mellitus, Type 2
1

Who runs them

Industry 6 · Other 0

Chendu DIAO Pharmaceutical Group CO., LTD. (6)

Studies

Open first, then newest update. How each study uses DA-302168S is read from its arms, and is right about nine times in ten.

Testing it · 6